Vascular Graft Market

Global Vascular Graft Market Size, Share:

The Global Vascular Graft Market is valued at USD 3.6 Billion in 2024 and is expected to reach USD 5.4 Billion by 2030 with a CAGR of 7.13% over the forecast period. The surging incidence of cardiovascular ailments, coupled with cutting-edge innovations in vascular graft technology, is fueling a robust demand for these life-saving conduits in the realm of cardiovascular health.

Scope of Global Vascular Graft Market Report-

A vascular graft is a medical device used to replace or repair damaged or diseased blood vessels. It is a type of surgical implant made of synthetic or biological materials that are designed to create a bypass around an obstructed or damaged blood vessel or to replace a damaged section of a blood vessel. Vascular grafts can be used in a variety of procedures, including coronary artery bypass surgery, peripheral vascular surgery, and dialysis access surgery. The type of graft used depends on the location and extent of the vascular problem, as well as the patient's overall health. Synthetic grafts are made of materials such as expanded polytetrafluoroethylene (ePTFE) or Dacron polyester, while biological grafts can be made from human tissue (such as veins) or animal tissue (such as bovine pericardium). In the 1950s, the first synthetic vascular grafts were developed using materials such as Dacron and Teflon.

The COVID-19 pandemic has had a negative impact on the vascular graft market. Like many other medical procedures, vascular surgeries have been affected by the pandemic due to delays in non-emergency surgeries, reduced hospital capacity, and the need to conserve resources for COVID-19 patients. This has resulted in a decline in the number of vascular surgeries performed, which has affected the demand for vascular grafts.

Global vascular graft market is segmented based on working product, graft material, end user and region. Based on Product, the vascular graft market is segmented into coronary artery bypass grafts, peripheral vascular grafts, endovascular stent grafts, haemodialysis access grafts. Based on Graft Material, the vascular graft market is segmented into polytetrafluoroethylene (Teflon), polyethylene terephthalate (Dacron), polyamide (nylon), polyurethanes. Based on end user the vascular graft market is segmented into hospitals, ambulatory surgical centres, cardiac catheterization labs and others.

The regions covered in this vascular graft market are North America, Europe, Asia-Pacific, Latin, and the Middle East. Based on a country level, the market of Vascular Graft is subdivided into the U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, Southeast Asia, Middle East Asia (UAE, Saudi Arabia, Egypt) GCC, Africa, etc. 

Key Players for Global Vascular Graft Market Report– 

Some of the key players for Vascular Graft are Medtronic plc, Terumo Corporation, Cook Medical, LeMaitre Vascular, Inc., W. L. Gore & Associates, Inc., B. Braun Melsungen AG, Cardinal Health, Inc., Endologix, Inc., Maquet Getinge Group, Cordis Corporation, CryoLife, Inc., Vascutek Ltd., Artegraft, Inc., Labcor Laboratórios Ltd., Humacyte, Inc., Atrium Medical Corporation, JOTEC GmbH, Lombard Medical Technologies, Perouse Medical, Shanghai Suokang Medical Implants Co., Ltd., Lifeline Scientific, Inc., Bolton Medical, Heart Medical Europe B.V, Veryan Medical Ltd., CryoLife Europe Ltd., Meril Life Sciences Pvt. Ltd., Artegraft, Inc., Sartorius AG, Gelantis, BD. Others.

News: - 

FDA Approves Expanded Indication for Gore Cardiovascular Stent Graft for Treatment of Aortic Dissection

March 2^nd, 2022 - The Gore Cardiovascular Stent Graft, a device used in the treatment of aortic dissection, had received an expanded indication from the U.S. Food and Drug Administration (FDA). The expanded indication allowed for the use of the device in patients with aortic dissection involving the descending thoracic aorta. Previously, the device was approved for use in patients with abdominal aortic aneurysms and thoracic aortic aneurysms. The Gore Cardiovascular Stent Graft served as a minimally invasive option for treating aortic dissection, which was a serious condition that could lead to life-threatening complications if left untreated. This approval provided another treatment option for patients with aortic dissection and expanded the use of the device in the cardiovascular market.

Endologix Receives Fda Approval for Alto Abdominal Stent Graft System

October 28^th, 2022 - Endologix, a medical device company renowned for its expertise in aortic disorder treatment, has proudly disclosed the U.S. FDA's granted approval for its revolutionary Alto Abdominal Stent Graft System. The Alto system is designed to treat patients with abdominal aortic aneurysms (AAA), a potentially life-threatening condition that occurs when the wall of the aorta weakens and bulges. The system consists of a flexible stent graft that is delivered through a catheter and expands to fit inside the damaged area of the aorta.

Global Vascular Graft Market Dynamics– 

The increasing prevalence of cardiovascular diseases is one of the key factors driving the demand for vascular grafts market. Cardiovascular diseases, including coronary artery disease, peripheral artery disease, and aneurysms, are among the leading causes of death worldwide. For instance, in 2021, according to the World Health Organization (WHO), cardiovascular diseases account for approximately 17.9 million deaths each year, representing 31% of all global deaths. As the population ages and lifestyles become more sedentary, the incidence of these diseases is expected to continue to rise.

Besides, Vascular grafts are a critical component of the treatment for many cardiovascular diseases. They are used to bypass obstructed or damaged blood vessels, restore blood flow, and prevent further damage. In many cases, vascular grafts can help patients avoid more invasive surgeries or amputations.

Overall, the increasing prevalence of cardiovascular diseases is likely to continue driving growth in the vascular graft market, as healthcare providers seek to provide effective and minimally invasive treatments to their patients.

Moreover, the vascular graft market has been driven by various technological advancements that have improved the outcomes of vascular surgeries and expanded the range of conditions that can be treated with these devices. The development of tissue-engineered grafts is one of the examples of technological advancements in vascular grafts. Tissue-engineered grafts promote natural healing and regeneration and reduce the risk of rejection, expanding the range of conditions that can be treated with these devices.

Also, 3D printing technology has been used to create patient-specific vascular grafts that fit the patient's anatomy, reducing the risk of complications, and improving the overall outcome of the surgery. For instance, according to a study published in the journal of Vascular Surgery in 2021 3D-printed vascular grafts are cost effective compared to traditional synthetic vascular grafts for use in peripheral arterial disease (PAD) patients. In conclusion, technological advancements in vascular grafts have contributed to the growth of the vascular graft market by improving outcomes, expanding the range of conditions that can be treated, and increasing demand.

However, the high cost of vascular surgeries, stringent regulatory requirements, lack of awareness all these factors are affecting the growth of vascular graft market. Furthermore, increasing geriatric population, availability of skilled surgeons, increasing healthcare expenditure is growing the demand for vascular graft in future.

Global Vascular Graft Market Regional Analysis– 

North America commands the foremost position in the vascular graft market, primarily attributable to the widespread prevalence of cardiovascular ailments and the robust healthcare infrastructure in place. For instance, in 2023, heart-related fatalities in the United States will occur every 33 seconds, with approximately 695,000 people succumbing to heart disease in 2021, equating to 1 in every 5 deaths. The region's market growth is further propelled by the escalating demand for minimally invasive surgical procedures and the increasing adoption of cutting-edge vascular grafts.

Additionally, the presence of prominent market players, augmented healthcare expenditures, a high rate of advanced vascular graft adoption, and a burgeoning elderly population collectively bolster the market's expansion in North America.

Europe, the second-largest influential region in the vascular graft market, is witnessing substantial growth. This growth is propelled by a burgeoning elderly population and a notable prevalence of cardiovascular diseases. For instance, the European Society of Cardiology reports—cardiovascular disease (CVD) annually accounts for 3.9 million fatalities in Europe and over 1.8 million in the European Union.

The demand for minimally invasive surgical techniques and the increasing adoption of cutting-edge tissue-engineered grafts and other advanced vascular grafts are poised to be key growth drivers. Furthermore, the presence of established industry leaders within the region, coupled with their unwavering commitment to pioneering research and the development of innovative products, is poised to steer the growth of the vascular graft market in Europe.

Key Benefits of Global Vascular Graft Market Report– 

• Global Vascular Graft Market report covers in-depth historical and forecasts analysis.
• Vascular Graft market research report provides detailed information about market introduction, market summary, global market revenue (Revenue USD), market drivers, market restraints, market opportunities, competitive analysis, regional and country level.
• Vascular Graft market report helps to identify opportunities in the marketplace.
• Vascular Graft market report covers extensive analysis of emerging trends and competitive landscape. 

Global Vascular Graft Market Segmentation: – 

By Product:

• Coronary Artery Bypass Grafts
• Peripheral Vascular Grafts
• Endovascular Stent Grafts
• Hemodialysis Access Grafts

By Graft Material: 

• Polytetrafluoroethylene (Teflon)
• Polyethylene Terephthalate (Dacron)
• Polyamide (Nylon)
• Polyurathanes

By End user: 

• Hospitals
• Ambulatory Surgical centers
• Cardiac Catheterization Labs
• Others

By Regional & Country Analysis: 

• North America
• S.
• Canada 
• Europe
• Germany
• France
• UK
• Italy
• Spain
• Rest of Europe
• The Asia Pacific
• China
• Japan
• India
• Southeast Asia
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Columbia
• Rest of Latin America
• The Middle East and Africa
• GCCcountries
• Africa
• Rest of the Middle East and Africa